POH
Click for more information
0.00% 0.0¢ progress 2023-2 trust

PMCould have something to do with this approval this year for...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. FullMoonFever
    4,498 Posts.
    lightbulb Created with Sketch. 310
    clock Created with Sketch.
    14/11/18
    17:07
    Post #: 36505160
    PM

    Could have something to do with this approval this year for Mylan Dapto and being placed under their label as per a prev recent POH Ann. 

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205037

    I am assuming if our agreement has strict requirements re a generic Dapto being approved and sold then it could imply that mylan have not adhered to developing a TPM Dapto as per agreement opting to produce generic first against terms of agreement. 

    Hence why POH indicate they have to weigh up their options on that as a breach maybe. 
    POH Price at posting: 0.3¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add POH (ASX) to my watchlist
(20min delay)
Last
0.0¢ 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
POH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.